Alzheimer’s Amyloid-Clearing Monoclonal Antibody Drug Lecanemab Shows Positive Results, Poised for FDA Approval
Alzheimer’s Amyloid-Clearing Monoclonal Antibody Drug Lecanemab Shows Positive Results, Poised for FDA Approval
Meet Orbit, the Interactive Robot That Looks to Help Children With Autism Spectrum Disorders Develop Social Skills
New Method Enables Long-Lasting Imaging of Rapid Brain Activity in Individual Cells Deep in the Cortex
The Green Mediterranean Diet Reduces Twice as Much Visceral Fat as the Mediterranean Diet and 10% More Than a Healthy Diet
FeaturedNeurosciencePsychology·August 22, 2021·6 min readBeing Chased, Losing Your Teeth or Falling Down? What Science Says About Recurring DreamsTwo-thirds of people report experiencing recurring dreams, especially during times of stress. Researchers evaluate how the phenomenon occurs, and factors that contribute to recurring dreams.Read More
Alzheimer’s Amyloid-Clearing Monoclonal Antibody Drug Lecanemab Shows Positive Results, Poised for FDA Approval
